The abortion rate is holding steady in the US despite total and partial bans in some states – largely because of travel across state lines and a significant increase in telehealth appointments, a new report says.
US regulatory officials are weighing changes to the ways mifepristone, an abortion medication, may be dispensed, but they have reportedly pushed their review until after the midterm elections, given the widespread support for abortion across the US.
The number of abortions in the US increased slightly last year, from 1.124m to 1.126m, according to a Guttmacher Institute report. There’s also a shift away from traveling and toward telehealth, in which providers may prescribe mail-order pills.
One major change in this report is the provision of telehealth for patients in states with total bans – with clinicians in states such as New York or Massachusetts, which have shield laws to protect providers, seeing and prescribing remotely to patients living in states such as Texas or Alabama.
At the MAHA Institute's "Mental Health & Overmedicalization Summit" in the nation's capital, the Health and...
The Supreme Court on May 4 reinstated mail-order access to the widely used abortion drug mifepristone,...
